Lack of association of ACP1 gene with inflammatory bowel disease: A case-control study

Tissue Antigens

Volumn 80, Issue 1, 2012, Pages 61-64

  Teruel, M ^a   Martin, J E ^a   Gomez Garcia M ^b   Cardena C ^c   Rodrigo, L ^d   Nieto, A ^e   Alcain, G ^f   Cueto, I ^f   Lopez Nevot M A ^b   Martin, J ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^c HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

Author keywords

Crohn's disease; Polymorphisms; Single nucleotide polymorphism; Susceptibility

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE 1; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; COLON; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; ILEUM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT;

CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN TYROSINE PHOSPHATASES; PROTO-ONCOGENE PROTEINS; SPAIN;

EID: 84862799294     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01861.x     Document Type: Article

References (31)

1. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol 2010: 28: 573-621.
2. Budarf ML, Labbe C, David G, Rioux JD. GWA studies: rewriting the story of IBD. Trends Genet 2009: 25: 137-46.
3. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011: 140: 1704-12.
4. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011: 474: 307-17.
5. Anderson CA, Massey DC, Barrett JC et al. Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009: 136: 523-9.e3.
6. Lazaruk KD, Dissing J, Sensabaugh GF. Exon structure at the human ACP1 locus supports alternative splicing model for f and s isozyme generation. Biochem Biophys Res Commun 1993: 196: 440-6.
7. Dissing J. Immunochemical characterization of human red cell acid phosphatase isozymes. Biochem Genet 1987: 25: 901-18.
8. Bottini N, Stefanini L, Williams S et al. Activation of ZAP-70 through specific dephosphorylation at the inhibitory Tyr-292 by the low molecular weight phosphotyrosine phosphatase (LMPTP). J Biol Chem 2002: 277: 24220-4.
9. Chiarugi P, Cirri P, Raugei G, Manao G, Taddei L, Ramponi G. Low M(r) phosphotyrosine protein phosphatase interacts with the PDGF receptor directly via its catalytic site. Biochem Biophys Res Commun 1996: 219: 21-5.
10. Kikawa KD, Vidale DR, Van Etten RL, Kinch MS. Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation. J Biol Chem 2002: 277: 39274-9.
11. Pandey SK, Yu XX, Watts LM et al. Reduction of low molecular weight protein-tyrosine phosphatase expression improves hyperglycemia and insulin sensitivity in obese mice. J Biol Chem 2007: 282: 14291-9.
12. Rigacci S, Rovida E, Bagnoli S, Dello Sbarba P, Berti A. Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. FEBS Lett 1999: 459: 191-4.
13. Taddei ML, Chiarugi P, Cirri P et al. LMW-PTP exerts a differential regulation on PDGF- and insulin-mediated signaling. Biochem Biophys Res Commun 2000: 270: 564-9.
14. Rigacci S, Rovida E, Dello Sbarba P, Berti A. Low Mr phosphotyrosine protein phosphatase associates and dephosphorylates p125 focal adhesion kinase, interfering with cell motility and spreading. J Biol Chem 2002: 277: 41631-6.
15. Bottini E, Bergamaschi A, Magrini A et al. Allergy and ACP1 genetic polymorphism. Allergy Asthma Proc 2007: 28: 87-92.
16. Bottini N, Otsu A, Borgiani P et al. Genetic control of serum IgE levels: a study of low molecular weight protein tyrosine phosphatase. Clin Genet 2003: 63: 228-31.
17. Banci M, Saccucci P, D'Annibale F et al. ACP1 genetic polymorphism and coronary artery disease: an association study. Cardiology 2009: 113: 236-42.
18. Bottini E, Gloria-Bottini F, Borgiani P. ACP1 and human adaptability. 1. Association with common diseases: a case-control study. Hum Genet 1995: 96: 629-37.
19. Teruel M, Martin JE, Gonzalez-Juanatey C et al. Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients. Arthritis Res Ther 2011: 13: R116.
20. Teruel M, Martin JE, Ortego-Centeno N et al. Novel association of acid phosphatase locus 1*C allele with systemic lupus erythematosus. Hum Immunol 2012: 73: 107-10.
21. Bottini N, Gloria-Bottini F, Lucarini N, Ronchetti PG, Fontana L. Inflammatory bowel disease: are there gender differences in the genetics of signal transduction? A preliminary study of cytosolic low molecular weight protein tyrosine phosphatase. Dis Markers 2000: 16: 163-6.
22. Gloria-Bottini F, Bottini N, Renzetti G, Bottini E. ACP1 and Th class of immunological disease: evidence of interaction with gender. Int Arch Allergy Immunol 2007: 143: 170-6.
23. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989: 170: 2-6. Discussion.
24. Bottini N, Bottini E, Gloria-Bottini F, Mustelin T. Low-molecular-weight protein tyrosine phosphatase and human disease: in search of biochemical mechanisms. Arch Immunol Ther Exp (Warsz) 2002: 50: 95-104.
25. Shu YH, Hartiala J, Xiang AH et al. Evidence for sex-specific associations between variation in acid phosphatase locus 1 (ACP1) and insulin sensitivity in Mexican-Americans. J Clin Endocrinol Metab 2009: 94: 4094-102.
26. Purcell S, Neale B, Todd-Brown K et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007: 81: 559-75.
27. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005: 21: 263-5.
28. Skol AD, Scott LJ, Abecasis GR, Boehnke M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 2006: 38: 209-13.
29. Gasche C, Scholmerich J, Brynskov J et al. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000: 6: 8-15.
30. Souza AC, Azoubel S, Queiroz KC, Peppelenbosch MP, Ferreira CV. From immune response to cancer: a spot on the low molecular weight protein tyrosine phosphatase. Cell Mol Life Sci 2009: 66: 1140-53.
31. Apelt N, da Silva AP, Ferreira J et al. ACP1 genotype, glutathione reductase activity, and riboflavin uptake affect cardiovascular risk in the obese. Metabolism 2009: 58: 1415-23.